Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K241823
    Date Cleared
    2024-08-30

    (67 days)

    Product Code
    Regulation Number
    880.5440
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K240433, K241071, K230343, K192075, K192075/S001, K222929

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The ToxiSeal™ Vial Adaptor mechanically prohibits environments from entering the system and the escape of drug or vapor concentrations from the system, thereby minimizing individual and environmental exposure to drug vapor, aerosols, and spills. The device also prevents the introduction of microbial contaminations into the drug or fluid path for up to 168 hours (or 7 days) when used as intended.

    Device Description

    The ToxiSeal™ Vial Adaptor devices are single-use, sterile, non-pyrogenic CSTD drug vial adaptors that are fitted to the drug vials and are sealed against the closures of the vials. They are used as sterile interfaces between the drug vials and the ProSeal™ Injector or the ProSeal™ Injector Plus (both are syringe adaptors) for the injection of diluents into the drug vials and/or withdrawal of liquids from the vials. Changes proposed in this Special 510(k) Submission are as follow: Removed external balloon and added activated carbon filter.

    AI/ML Overview

    The provided document is a 510(k) summary for the ToxiSeal™ Vial Adaptor (K241823). It describes the device, its intended use, a comparison to a predicate device, and performance data supporting its substantial equivalence. However, the document does not contain information about an AI/software device or a comparative effectiveness study involving human readers with and without AI assistance.

    Therefore, I cannot provide information for points 5, 8, and 9 of your request as they are not present in the document.

    Based on the available information regarding the medical device itself (ToxiSeal™ Vial Adaptor), here's the information related to acceptance criteria and the studies conducted:

    The ToxiSeal™ Vial Adaptor is a physical medical device, not an AI/software product. Therefore, the "acceptance criteria" and "study that proves the device meets acceptance criteria" are related to its functional performance, biocompatibility, and sterility, rather than AI performance metrics.

    Acceptance Criteria and Device Performance (for a physical device)

    The document outlines the various tests performed to demonstrate the device's conformance to recognized standards. The "acceptance criteria" are implied by the conformance to these standards and the findings that the device "met the acceptance criteria therein" or "did not raise any new or different questions of safety or effectiveness."

    Here's a table summarizing the acceptance criteria (standards/tests) and the reported device performance.

    CategoryAcceptance Criteria (Standards/Tests)Reported Device Performance
    Functional Performance- ISO 8536-2:2010 (Infusion equipment for medical use – Part 2: Closures for infusion bottles) - Evaluated to be in conformance.
    - ISO 8536-4:2019 (Infusion equipment for medical use Part 4: Infusion sets for single use, gravity feed) - Evaluated to be in conformance.
    - ISO 8871-5:2016 (Elastomeric parts for parenterals and for devices for pharmaceutical use Part 5: Functional requirements and testing) - Evaluated to be in conformance.
    - ISO 22413:2021 (Transfer sets for pharmaceutical preparations – Requirements and test methods) - Evaluated to be in conformance.
    - Leak integrity testing (air- and liquid-tightness) per ISO 8536-4:2019, paragraph 7.2 and Annex A.3 - Performed successfully on both Subject and predicate devices; differences in design (activated carbon filter, no external balloon) "did not raise any new or different questions of safety or effectiveness."
    - Fragmentation study to ISO 22413 & ISO 8871-5 - Performed successfully on predicate device (K241476), implying substantial equivalence for the subject device.
    - Vial Adaptor penetration force testing to ISO 22413 - Performed successfully on predicate device (K241476), implying substantial equivalence for the subject device.
    - Tests for leakages to ISO 8536-4:2019, Annex A.3.3 - Performed successfully on the Subject device; differences in design "did not raise any new or different questions of safety or effectiveness."
    - Testing to (draft) NIOSH CSTD Test Protocol and NIOSH 2016, Performance Test Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs - Performed successfully on the Subject device and a previously cleared device (K222929); differences in design "did not raise any new or different questions of safety or effectiveness."
    - Microbial ingress/ microbiological integrity testing - Conducted successfully on a previously cleared device (K222929), indicating prevention of microbial contamination for up to 168 hours (7 days).
    Biocompatibility- ISO 10993-1: 2018 (Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process) - Classified as: Externally Communicating Device, Blood Path Indirect, Prolonged Contact (>24hr to 30d). - Referencing previous successful testing on existing devices of the ProSeal™ CSTD system (K192075, K192075/S001, K222929) for: Cytotoxicity (ISO 10993-5), Sensitization (ISO 10993-10), Intracutaneous Reactivity (ISO 10993-10), Acute Systemic Toxicity (ISO 10993-11), 14-day Subacute/ Subchronic Acute Systemic Toxicity (ISO 10993-11), In-vitro Hemolysis Assessment (ISO 10993-4), Material Mediated Pyrogenicity (ISO 10993-11), Chemical Characterization and Toxicological Risk Management (ISO 10993-18 and ISO 10993-17). The subject device is deemed biocompatible based on these references.
    - USP Particulate Matter in Injections - Testing conducted on devices under K192075 and K222929, and "found to have met the acceptance criteria therein." This performance is leveraged for the subject device.
    Sterility & Shelf-Life- ISO 11135:2014 (Sterilization of Health Care Products – Ethylene Oxide – Part 1: Requirements for Development, Validation and Routine Control of a Sterilization Process for Medical Devices) - "Comply with sterilization requirements."
    - Package Integrity Tests per ASTM F1980-21 (Standard guide for accelerated aging of sterile barrier systems for medical devices), ASTM F88/F88M-21 (Seal strength), ASTM F1929-23 (Dye Penetration), EN 868-5:2009 (Heat and self-sealable pouches and reels) - Performed on the proposed device (referencing K222929) and ensure package integrity.
    - Pyrogen Tests per ANSI/AAMI ST72/2019, USP 40, USP-NF , USP-NF - Conducted under K222929, with testing to be conducted on every lot.
    - Validated shelf-life using ASTM 1980-21 - A shelf-life of 3 years (36 months) has been validated.

    Now addressing the specific points of your request based on the provided document:

    1. A table of acceptance criteria and the reported device performance

      • See the table above. Note that for a physical medical device, "acceptance criteria" are typically defined by conformance to established performance standards and successful completion of specified tests.
    2. Sample sizes used for the test set and the data provenance (e.g., country of origin of the data, retrospective or prospective)

      • Sample Sizes: The document does not specify the exact sample sizes used for each performance test (e.g., number of devices tested for leak integrity, biocompatibility, etc.). It mentions that tests were "performed on the Subject devices," "on devices under K241476," or "on device under K222929," implying samples were used from these device types.
      • Data Provenance: The document does not explicitly state the country of origin of the data or whether the studies were retrospective or prospective. Given it's a 510(k) submission to the FDA, the data would typically be generated by the manufacturer or contract labs following international and US standards. The studies, being part of device verification and validation prior to market clearance, are generally prospective in nature for the tests conducted on the subject device.
    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

      • This question is not applicable to this type of medical device submission. Ground truth established by experts (like radiologists for imaging AI) is relevant for diagnostic accuracy studies of software/AI. For a physical device like a vial adaptor, the "ground truth" is based on objective measurements against established engineering and biological standards. There are no human "experts" establishing a diagnostic ground truth here.
    4. Adjudication method (e.g., 2+1, 3+1, none) for the test set

      • This question is not applicable as there is no diagnostic test set or human interpretation being adjudicated. The tests are quantitative and involve laboratory measurements.
    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

      • Not applicable. This document describes a physical medical device, not an AI software. No MRMC study was conducted or is relevant for this device.
    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

      • Not applicable. This is not an algorithm/AI device. The device's performance is standalone in the sense that its mechanical and biological properties are tested independently.
    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

      • The "ground truth" for this medical device is the objective measurement of physical properties, chemical properties, and biological safety against predefined engineering, material, and biocompatibility standards. Examples include:
        • Meeting specific leakage rates.
        • Absence of fragmentation.
        • Demonstrating specified penetration force.
        • Absence of microbial ingress.
        • Absence of cytotoxicity, sensitization, systemic toxicity, pyrogenicity, and meeting particulate matter limits.
        • Maintaining sterility over shelf-life.
      • It's based on quantitative laboratory testing results compared to acceptance criteria defined by recognized standards (ISO, ASTM, USP, NIOSH).
    8. The sample size for the training set

      • Not applicable. This is not an AI/machine learning device; there is no "training set."
    9. How the ground truth for the training set was established

      • Not applicable. As there is no training set for an AI model, this question does not apply.
    Ask a Question

    Ask a specific question about this device

    K Number
    K241476
    Date Cleared
    2024-06-21

    (28 days)

    Product Code
    Regulation Number
    880.5440
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K240433, K192075, K192075/S001, K240171, K241071

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The ToxiSeal™ Vial Adaptor with External Flip Balloon mechanically prohibits environmental contaminants from entering the system and the escape of drug or vapor concentrations from thereby minimizing individual and environmental exposure to drug vapor, aerosols, and spills. The device also prevents the introduction of microbial contaminations into the drug or fluid path for up to 168 hours (or 7 days) when used as intended.

    Device Description

    The ToxiSeal™ Vial Adaptor with External Flip Balloon devices are single-use, sterile, nonpyrogenic CSTD drug vial adaptors that are fitted to the drug vials and are sealed against the closures of the vials. They are used as sterile interfaces between the drug vials and the ProSeal™ Injector or the ProSeal™ Injector Plus (both are syringe adaptors) for the injection of diluents into the drug vials and/or withdrawal of liquids from the vials. In addition, the ToxiSeal™ Vial Adaptor with External Flip Balloon devices equalize the pressure difference which occurs when fluid or air is added to or removed from the drug vial. This neutral pressure is maintained utilizing an external balloon/ expansion chamber.

    AI/ML Overview

    This is a 510(k) summary for a medical device called "ToxiSeal™ Vial Adaptor with External Flip Balloon". This submission seeks to demonstrate that the new device, which has some material and design changes compared to a previously cleared predicate device, is substantially equivalent and does not require a new premarket approval application.

    Here's an analysis of the provided information concerning acceptance criteria and supporting studies, formatted as requested:

    1. Table of Acceptance Criteria and Reported Device Performance

    The document does not explicitly present a table of acceptance criteria with corresponding performance results in a comparative format for each specific criterion. Instead, it lists the standards and types of tests performed, implying that the device met the requirements of these standards. The "Reported Device Performance" in this context refers to the affirmation that testing was conducted and demonstrated conformance with the cited standards and previously cleared devices' performance.

    Acceptance Criterion (Standard or Test Type)Reported Device Performance
    Fragmentation study to ISO 22413 & ISO 8871-5Performed on the Subject device; met criteria (implied)
    Vial Adaptor penetration force testing to ISO 22413Performed on the Subject device; met criteria (implied)
    Tests for leakages to ISO 8536-4:2019, Annex A.3Performed on the Subject device; met criteria (implied)
    Volume of pressure equalization studyLeveraged from K222929; met criteria (implied)
    Testing to (draft) NIOSH CSTD Test ProtocolLeveraged from K222929; met criteria (implied)
    Microbial ingress/ microbiological integrity testingLeveraged from K222929; met criteria (implied)
    Biocompatibility (Cytotoxicity to ISO 10993-5)Leveraged from K192075; met criteria (implied)
    Biocompatibility (Sensitization to ISO 10993-10)Leveraged from K192075; met criteria (implied)
    Biocompatibility (Intracutaneous Reactivity to ISO 10993-10)Leveraged from K192075; met criteria (implied)
    Biocompatibility (Acute Systemic Toxicity to ISO 10993-11)Leveraged from K192075; met criteria (implied)
    Biocompatibility (14-day Subacute/ Subchronic Acute Systemic Toxicity to ISO 10993-11)Leveraged from K192075; met criteria (implied)
    Biocompatibility (In-vitro Hemolysis Assessment to ISO 10993-4)Leveraged from K192075 and K192075/S001; met criteria (implied)
    Biocompatibility (Material Mediated Pyrogenicity to ISO 10993-11)Leveraged from K192075; met criteria (implied)
    Biocompatibility (Chemical Characterization and Toxicological Risk Management to ISO 10993-18 and ISO 10993-17)Leveraged from K192075/S001; met criteria (implied)
    Particulate matter testing (USP )Met the acceptance criteria therein
    Sterilization (ISO 11135: 2014)Complies with requirements (implied)
    Package Integrity Tests (ASTM F1980-16, ASTM F88/F88M-21, ASTM F1929-15, EN 868-5: 2009)Performed on the proposed device; met criteria (implied)
    Pyrogen Tests (ANSI/AAMI ST72/ 2019, USP 40 , USP-NF , USP-NF )Performed; met criteria (implied)
    Shelf-life validation (ASTM 1980-16)3 years (36 months) validated

    2. Sample Sizes Used for the Test Set and Data Provenance

    • Sample Sizes: The document does not explicitly state the specific number of units or samples used for each individual test. It mentions that testing was performed "on the Subject device" or "on test samples in their finished form aged to the intention i the Subject device validation lots."
    • Data Provenance: The document does not specify the country of origin of the data. The studies are described as "bench performance verifications and validations" and refer to past clearances (K222929, K240433, K192075) for much of the leveraged data, implying these were laboratory-based tests. The submission originates from Singapore.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications

    This information is not applicable to this type of device submission. The device is a physical medical device (vial adaptor), not an AI/ML-based diagnostic or prognostic tool that would require expert-established ground truth for a test set. The validation relies on technical performance standards and biocompatibility.

    4. Adjudication Method for the Test Set

    This information is not applicable for the same reasons as point 3.

    5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study Was Done, and Effect Size

    This information is not applicable. This is not an AI/ML-based diagnostic device where reader studies would be relevant.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

    This information is not applicable. This is a physical medical device.

    7. The Type of Ground Truth Used

    The "ground truth" for this device's performance is established by conformance to recognized industry standards (ISO, ASTM, USP, ANSI/AAMI) for mechanical, chemical, biological, and sterility properties. For example:

    • Mechanical Integrity: Conformance to ISO 22413, ISO 8536-4.
    • Biocompatibility: Conformance to ISO 10993 series.
    • Sterility: Conformance to ISO 11135.
    • Particulate Matter: Conformance to USP .
    • Shelf-life: Conformance to ASTM 1980-16.

    8. The Sample Size for the Training Set

    This information is not applicable. This is a physical medical device, not an AI/ML system that utilizes a training set.

    9. How the Ground Truth for the Training Set Was Established

    This information is not applicable for the same reason as point 8.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1